Aug 03, 2016 12:14pm EDT OPKO to Announce Second Quarter Operating and Financial Results on August 8, 2016
Jun 21, 2016 2:00am EDT FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease
Jun 07, 2016 4:05pm EDT OPKO to Discuss Draft Coverage Determinations for 4Kscore® Test at 2016 Jefferies Healthcare Conference
May 27, 2016 8:30am EDT OPKO Health Receives Proposed/Draft Medicare Local Coverage Determination for 4Kscore® Test
May 11, 2016 8:30am EDT OPKO Announces Appointment of Douglass Laidlaw as Vice President of Medical Affairs
May 10, 2016 8:30am EDT OPKO Announces Appointment of Thomas Nusbickel as Senior Vice President of Pharmaceutical Marketing and Market Access